Investing.com - Sight Sciences (NASDAQ: SGHT) reported first quarter EPS of $-0.33, $0.05 worse than the analyst estimate of $-0.28. Revenue for the quarter came in at $19.3M versus the consensus estimate of $18.4M.
Guidance
Sight Sciences sees FY 2024 revenue of $81.00M-$85.00M versus the analyst consensus of $82.54M.
Sight Sciences's stock price closed at $5.61. It is up 30.77% in the last 3 months and down -44.12% in the last 12 months.
Sight Sciences saw 3 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Sight Sciences's stock price’s past reactions to earnings here.
According to InvestingPro, Sight Sciences's Financial Health score is "good performance".
Check out Sight Sciences's recent earnings performance, and Sight Sciences's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar